*,:before,:after{box-sizing:border-box;margin:0;padding:0}h1,h2,h3,h4,h5,h6,p,span{margin:0}ul{margin:0;padding:0;list-style:none}picture{margin:0;padding:0}button,a{color:currentColor;font-family:inherit;font-size:inherit;line-height:inherit;padding:0}
:root{--background-color-main:#f9e9e9;--bg-color-button-main:#faadad;--bg-color-button-secondary:#f9e9e9;--border-button:#737373;--border-error:#f50c0c;--bg-disabled:#c9b1bd;--bg-color-header:#eacaf5;--bg-color-icon-button:#fff;--bg-utility:#fff;--font:"TT Rounds Neue Variable", sans-serif;--font-weight-main:400;--font-weight-title:800;--font-weight-support:600;--font-width-main:100;--font-width-support:50;--font-size-main:16px;--font-size-title:36px;--font-size-h2:24px;--font-size-support:11px;--font-color:#000;--font-color-error:#f50c0c;--font-color-success:#52c41a;--category-gap:clamp(6px, 2.5vw, 16px)}
@font-face{font-family:TT Rounds Neue Variable;src:url("../media/TT Rounds Neue Trial Variable_0.41-__bl1hja81.ttf")format("truetype-variations"),url("../media/TT Rounds Neue Trial Variable_0.41-__bl1hja81.ttf")format("truetype");font-weight:100 900;font-style:normal;font-display:swap}